Press releases & Latest news
55 % Overall Response Rate on the safety extension cohorts of the ISO-CC-005 Phase I/IIa study
GOTHENBURG, Sweden, September 30, 2020 – Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today provided an…
Strengthened patent protection for arfolitixorin in Japan
GOTHENBURG, Sweden, September 1, 2020 – Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), has announced today…
Invitation to a conference call and webcast by Isofol in connection with the entered license agreement with Solasia
GOTHENBURG, Sweden, August 13, 2020 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) has today…
Upcoming Events
- October 26, 2020 - October 29, 2020
BioEurope Fall - digital - November 13, 2020 - November 13, 2020
Interim Report Q3 2020 - November 26, 2020 - November 26, 2020
RedEye: Life Science Day
Isofol will attending Redeye´s event "Life Science Day" in Stockholm. The seminar will also be broadcast live.